These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 16534098

  • 1. Futility studies: spending a little to save a lot.
    Schwid SR, Cutter GR.
    Neurology; 2006 Mar 14; 66(5):626-7. PubMed ID: 16534098
    [No Abstract] [Full Text] [Related]

  • 2. The cost of delaying treatment in multiple sclerosis: what is lost is not regained.
    Barton J, Benatar M.
    Neurology; 2002 Feb 26; 58(4):668; author reply 668. PubMed ID: 11922032
    [No Abstract] [Full Text] [Related]

  • 3. Bedside to bench: betting on B cells in multiple sclerosis.
    Link H.
    Nat Med; 2008 Jun 26; 14(6):615-6. PubMed ID: 18535578
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treat MS proactively in managed care setting.
    Capitation Rates Data; 2004 Apr 26; 9(4):44-5. PubMed ID: 15162596
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].
    Kling A, Dahlqvist R.
    Lakartidningen; 2004 Apr 26; 104(3):128-30. PubMed ID: 17302117
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of multiple sclerosis with immunoglobulin G].
    Rothfelder U, Neu I, Pelka R.
    MMW Munch Med Wochenschr; 1982 Jan 29; 124(4):74-8. PubMed ID: 6801483
    [No Abstract] [Full Text] [Related]

  • 9. Economic evidence in multiple sclerosis: a review.
    Kobelt G.
    Eur J Health Econ; 2004 Oct 29; 5 Suppl 1():S54-62. PubMed ID: 15754075
    [No Abstract] [Full Text] [Related]

  • 10. MRI as an outcome in multiple sclerosis clinical trials.
    Tenser RB.
    Neurology; 2009 Dec 01; 73(22):1933-4; author reply 1934. PubMed ID: 19949044
    [No Abstract] [Full Text] [Related]

  • 11. The transition from phase II to phase III studies.
    Berthold DR, Gulamhusein A, Jackson JI, Tannock IF.
    J Clin Oncol; 2009 Mar 01; 27(7):1150-1. PubMed ID: 19171698
    [No Abstract] [Full Text] [Related]

  • 12. Low-dose naltrexone for treatment of multiple sclerosis: clinical trials are needed.
    Patel PN.
    Ann Pharmacother; 2007 Sep 01; 41(9):1549-50. PubMed ID: 17623758
    [No Abstract] [Full Text] [Related]

  • 13. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs.
    Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC, NET-PD Investigators.
    Neurology; 2006 Mar 14; 66(5):628-33. PubMed ID: 16534099
    [Abstract] [Full Text] [Related]

  • 14. [Mitoxantrone for the treatment of patients with multiple sclerosis].
    Komori M, Kondo T, Tanaka M.
    Brain Nerve; 2009 May 14; 61(5):575-80. PubMed ID: 19514518
    [Abstract] [Full Text] [Related]

  • 15. Daclizumab treatment for multiple sclerosis.
    Kim SE.
    Pharmacotherapy; 2009 Feb 14; 29(2):227-35. PubMed ID: 19170591
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quality of life and cost of multiple sclerosis.
    Miltenburger C, Kobelt G.
    Clin Neurol Neurosurg; 2002 Jul 14; 104(3):272-5. PubMed ID: 12127667
    [No Abstract] [Full Text] [Related]

  • 18. Design of phase II ALS clinical trials.
    Schoenfeld DA, Cudkowicz M.
    Amyotroph Lateral Scler; 2008 Jul 14; 9(1):16-23. PubMed ID: 18273715
    [Abstract] [Full Text] [Related]

  • 19. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z, Hazan R, Barak Y, Achiron A.
    Autoimmun Rev; 2006 Oct 14; 5(8):511-6. PubMed ID: 17027884
    [Abstract] [Full Text] [Related]

  • 20. Interferon-beta for multiple sclerosis: Long-term benefits?
    Rudick RA, Cutter G.
    Ann Neurol; 2007 Apr 14; 61(4):283-5. PubMed ID: 17444503
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.